Earth Science Tech (ETST) Income from Non-Controlling Interests (2025 - 2026)
Earth Science Tech's (ETST) quarterly Income from Non-Controlling Interests came in at -$580.0 in Q1 2026, down 6344.44% on a QoQ basis from -$9.0 in Q4 2025.
Earth Science Tech (ETST) Income from Non-Controlling Interests (2025 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 2 years of Income from Non-Controlling Interests data on file, last reported at -$580.0 in Q1 2026.
- Quarterly Income from Non-Controlling Interests changed N/A year-over-year to -$580.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$29840.0 (changed N/A YoY) and the FY2026 annual result came in at -$29839.0, changed N/A from the prior year.
- Income from Non-Controlling Interests retreated to -$580.0 in Q1 2026, from -$9.0 in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of -$9.0 in Q4 2025 to a low of -$20926.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | 376,434.15 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Earth Science Tech | 31.63 Mn | 28.84 Mn | 6.28 Mn | -8,495.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8,495.00 |
| Mar 31, 2026 | -580.00 |
| Dec 31, 2025 | -9.00 |
| Sep 30, 2025 | -20,926.00 |
| Jun 30, 2025 | -8,325.00 |